Overview

Normothermic Ex Vivo Lung Perfusion (EVLP) For An Improved Assessment of Donor Lungs For Transplantation

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The use of ex vivo lung perfusion (EVLP) will allow for a secondary evaluation technique for donor lungs that fail to meet standard acceptability criteria. This advanced assessment might lead to increased utilization rates of donor lungs and improved outcomes after lung transplantation.
Phase:
Phase 1
Details
Lead Sponsor:
XVIVO Perfusion
Treatments:
Pharmaceutical Solutions